Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL 2: Peginesatide for Anemia in Chronic Renal Failure
NCT00598442Phase 3Completed
- Sponsor
- Affymax, Inc.
- Start
- Nov 2007
- Primary completion
- Jul 2009
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 10
01
Overview
A Phase 3 trial of peginesatide in anemia of chronic kidney disease (CKD-A), sponsored by Affymax, Inc.. Started Nov 2007; status: completed.
02
Drugs
peginesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00598442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598442.